These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2182420)

  • 1. Comparison of postremission therapies in adult acute myeloid leukemia: preliminary analysis of an ECOG study. Eastern Cooperative Oncology Group.
    Cassileth PA; Harrington DP; Hines JD; Oken MM; Mazza JJ; McGlave P; Bennett JM; Lynch E; O'Connell MJ
    Haematol Blood Transfus; 1990; 33():267-70. PubMed ID: 2182420
    [No Abstract]   [Full Text] [Related]  

  • 2. Remission induction and postremission therapy in acute myelogenous leukemia: British MRC Study.
    Rees JK; Gray RG
    Haematol Blood Transfus; 1990; 33():243-8. PubMed ID: 1691131
    [No Abstract]   [Full Text] [Related]  

  • 3. Sequential pilot studies of intensive postremission chemotherapy for acute nonlymphocytic leukemia.
    Petti MC; Avvisati G; Tafuri A; Meloni G; Amadori S; Mandelli F
    Ann N Y Acad Sci; 1987; 511():436-41. PubMed ID: 3326472
    [No Abstract]   [Full Text] [Related]  

  • 4. Preliminary results of intensive therapy of children and adolescents with acute nonlymphocytic leukemia--a Childrens Cancer Study Group report.
    Lampkin BC; Woods WG; Buckley JD; Hammond GD
    Haematol Blood Transfus; 1990; 33():210-4. PubMed ID: 1691130
    [No Abstract]   [Full Text] [Related]  

  • 5. Double intensive consolidation chemotherapy (ICC) for acute myeloid leukemia.
    Harousseau JL; Milpied N; Briere J; Desablens B; Le Prise PY; Ifrah N; Gandhour C; Casassus P
    Haematol Blood Transfus; 1990; 33():299-303. PubMed ID: 2323633
    [No Abstract]   [Full Text] [Related]  

  • 6. A randomized comparison of post-consolidation therapy in acute non-lymphoid leukaemia: a study of the Italian cooperative group GIMEMA.
    Petti MC; Mandelli F; Vegna ML; Broccia G; Carotenuto M; De Rosa F; Di Marco P; Di Raimondo F; Fioritoni G; Leone G
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():119-20. PubMed ID: 2653486
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute nonlymphocytic leukemia in adults: results obtained with TAD remission induction therapy.
    Witteveen EO; Verdonck LF; Nieuwenhuis HK; Dekker AW
    Haematol Blood Transfus; 1990; 33():309-13. PubMed ID: 2323635
    [No Abstract]   [Full Text] [Related]  

  • 8. A randomized comparison of intensive maintenance treatment for adult acute myelogenous leukemia using either cyclic alternating drugs or repeated courses of the induction-type chemotherapy: AML-6 trial of the EORTC Leukemia Cooperative Group.
    Jehn U; Zittoun R; Suciu S; Fiere D; Haanen C; Peetermans M; Löwenberg B; Willemze R; Solbu G; Stryckmans P
    Haematol Blood Transfus; 1990; 33():277-84. PubMed ID: 1691132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy of acute myelogenous leukemia in adults.
    Petti MC; Broccia G; Caronia F; Di Raimondo F; Fioritoni G; Ladogana S; Leone G; Liso V; Musso M; Neri A
    Haematol Blood Transfus; 1990; 33():249-53. PubMed ID: 2182417
    [No Abstract]   [Full Text] [Related]  

  • 10. High-dose cytarabine consolidation with or without additional amsacrine and mitoxantrone in acute myeloid leukemia: results of the prospective randomized AML2003 trial.
    Schaich M; Parmentier S; Kramer M; Illmer T; Stölzel F; Röllig C; Thiede C; Hänel M; Schäfer-Eckart K; Aulitzky W; Einsele H; Ho AD; Serve H; Berdel WE; Mayer J; Schmitz N; Krause SW; Neubauer A; Baldus CD; Schetelig J; Bornhäuser M; Ehninger G
    J Clin Oncol; 2013 Jun; 31(17):2094-102. PubMed ID: 23630210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of recurrent acute myelogenous leukaemia at a single centre over a 10-year period.
    Davis CL; Rohatiner AZ; Amess J; Lim J; Lister TA
    Haematol Blood Transfus; 1990; 33():339-41. PubMed ID: 2323639
    [No Abstract]   [Full Text] [Related]  

  • 12. Amsacrine, cytarabine and thioguanine (AAT) versus daunorubicin, cytarabine, thioguanine (DAT) in adults with untreated acute non-lymphoblastic leukemia (ANLL). Austrian-German results.
    Linkesch W; Michlmayr G; Gerhartz H; Illinger H; König H; Düllmann J; Keilhauer R; Moldrzyk D
    Onkologie; 1989 Feb; 12(1):8-10. PubMed ID: 2654791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Varying intensity of postremission therapy in acute myeloid leukemia.
    Cassileth PA; Lynch E; Hines JD; Oken MM; Mazza JJ; Bennett JM; McGlave PB; Edelstein M; Harrington DP; O'Connell MJ
    Blood; 1992 Apr; 79(8):1924-30. PubMed ID: 1562720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adult AML: the role of chemotherapy intensity and duration. Two studies of the AML Cooperative Group.
    Büchner T; Hiddemann W; Blasius S; Koch P; Maschmeyer G; Tirier C; Sodomann H; Kuse R; Thiel E; Ludwig WD
    Haematol Blood Transfus; 1990; 33():261-6. PubMed ID: 2182419
    [No Abstract]   [Full Text] [Related]  

  • 15. Intensive induction and consolidation chemotherapy for adults and children with acute myeloid leukaemia (AML) joint AML trial 1982-1985.
    Marcus RE; Catovsky D; Prentice HG; Newland AC; Chessells JM; Stevens RF; Hann IM; Goldman JM; Hoffbrand AV; Galton DA
    Haematol Blood Transfus; 1987; 30():346-51. PubMed ID: 2442074
    [No Abstract]   [Full Text] [Related]  

  • 16. Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. The Associazione Italiana Ematologia ed Oncologia Pediatrica Cooperative Group.
    Amadori S; Testi AM; Aricò M; Comelli A; Giuliano M; Madon E; Masera G; Rondelli R; Zanesco L; Mandelli F
    J Clin Oncol; 1993 Jun; 11(6):1046-54. PubMed ID: 8501490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA as a carrier for anthracyclines in the treatment of acute myelocytic leukemia (AML).
    Gahrton G; Tidefelt U; Paul C; Björkholm M; Grimfors G; Hast R; Juliusson G; Järnmark M; Killander A; Kimby E
    Leukemia; 1992; 6 Suppl 2():89-91. PubMed ID: 1578953
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative trial of cytarabine and thioguanine in combination with amsacrine or daunorubicin in patients with untreated acute nonlymphocytic leukemia: results of the L-16M protocol.
    Berman E; Arlin ZA; Gaynor J; Miller W; Gee T; Kempin SJ; Mertelsmann R; Andreeff M; Reich L; Nahmias N
    Leukemia; 1989 Feb; 3(2):115-21. PubMed ID: 2911205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose cytarabine in consolidation chemotherapy or with bone marrow transplantation for patients with acute leukemia: preliminary results.
    Champlin R; Jacobs A; Gale RP; Ho W; Selch M; Lenarsky C; Feig SA
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):190-5. PubMed ID: 3892702
    [No Abstract]   [Full Text] [Related]  

  • 20. Autologous bone marrow transplantation in acute myeloid leukemia in first remission: first Dutch prospective study.
    Löwenberg B; van Putten WL; Verdonck LF; Dekker AW; de Gast GC; Willemze R; Zwaan FE; Abels J; Sonneveld P; van der Lelie J
    Haematol Blood Transfus; 1990; 33():655-60. PubMed ID: 2182456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.